Prednisolone Acetate: Brands, Price & Uses in Bangladesh

Prednisolone Acetate ophthalmic suspension is a corticosteroid indicated for the treatment of steroid-responsive inflammatory conditions of the eye. Its established and guideline-supported uses include:

• Established/approved use: Steroid-responsive inflammation of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the globe, such as allergic conjunctivitis, acne rosacea (ocular), superficial punctate keratitis, herpes zoster keratitis (non-dendritic), iritis, and cyclitis.
• Established/approved use: Selected infective conjunctivitis, when the inherent hazard of steroid use is accepted and an anti-infective agent is co-administered to control the infection.
• Established/approved use: Reduction of inflammation and edema following ocular injury from chemical, radiation, or thermal burns, or penetration of foreign bodies.
• Established/approved use: Management of post-operative inflammation following ophthalmic surgery (e.g. cataract surgery).

Prednisolone Acetate is not indicated for use in undiagnosed "red eye" without prior ophthalmologic evaluation, since it may mask or worsen an underlying infection.

General Dosing

Shake the bottle well before each use, as Prednisolone Acetate is a suspension. Treatment should not be discontinued prematurely; the dose should be tapered gradually under medical supervision, as abrupt discontinuation may cause rebound inflammation.

If used together with an anti-infective agent for infective conjunctivitis, both medicines should be used exactly as prescribed. See Precautions and Warnings for monitoring requirements during prolonged use.

Side effects associated with Prednisolone Acetate ophthalmic suspension are usually local to the eye and include:

• Transient stinging, burning, or blurred vision immediately after instillation.
• Elevated intraocular pressure (IOP) / steroid-induced glaucoma with prolonged use, which may lead to optic nerve damage and visual field defects.
• Posterior subcapsular cataract formation with long-term use.
• Delayed corneal or scleral wound healing.
• Secondary ocular infection (bacterial, viral, or fungal) due to suppression of the host inflammatory response, or perforation of the globe where thinning of the cornea or sclera exists.
• Mydriasis (pupil dilation) and ptosis (drooping eyelid) have been reported infrequently.

Patients should promptly report eye pain, significant vision changes, or persistent redness to their physician.